a log-likelihood chi 2 test comparing lymphatic spread , recurrence rate , and 5-year disease-free survival in patients with stage ib disease and tumors less than 3 cm versus a similar group of 58 patients with pure squamous cell carcinoma of equivalent stage and comparable size treated during the same time disclosed no significant differences in any of the indicators analyzed .
C0012634
disease
C0027651
tumors